While biotech stocks saw a dip earlier this year due to market uncertainties, the sector is again gaining popularity as investors seek growth opportunities....
While biotech stocks saw a dip earlier this year due to market uncertainties, the sector is again gaining popularity as investors seek growth opportunities....
A single positive or negative announcement from the US Food and Drug Administration (FDA) can send shares of a biotech firm soaring.
On February 28th,...